The ABCB1 c.3435T allele has been implicated in treatment outcomes of the antimalarials artemether and lumefantrine [45], mefloquine [46], warfarin stable-dose frequency [47] and breast cancer chemotherapy [48]. The gene discussed is ABCB1; the disease is breast carcinoma.